Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM

View source ↗

Summary

A clinical trial update reports the psychometric validation of a novel patient-reported outcome measure for vulvovaginal atrophy (VVAQ) in women with vulvovagin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Vulvovaginal Atrophy, Menopause | Status: COMPLETED